Evaluation of Energy Drinks on Electrocardiographic, Vascular and Hematologic Parameters in Healthy Volunteers

NCT03021616 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

2

Enrollment

FED

Sponsor class

Stopped Results from sister study at University of the Pacific were conclusive.

Conditions

Cardiovascular Diseases

Interventions

OTHER: energy drink
OTHER: Moxifloxacin 400mg
OTHER: Placebo

Sponsor

David Grant U.S. Air Force Medical Center